Form 4 holding
SVP, Chief Medical Officer
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 13,341
- Estimated value
- $676,255
- Report date
- 25 Feb 2026
- Price
- $50.69
- Ownership
- Direct
Jonathan Rubin - SVP, Chief Medical Officer at SUPERNUS PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- SVP, Chief Medical Officer
- Issuer ticker
- SUPN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jonathan Rubin since 06 Aug 2025
Reported holdings for Jonathan Rubin in SUPERNUS PHARMACEUTICALS, INC.
Form 4 holding
SVP, Chief Medical Officer
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Unit
- Shares / value
- 1,250
- Estimated value
- $97,875
- Report date
- 25 Feb 2026
- Price
- $39.15
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Medical Officer
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Performance Share Unit
- Shares / value
- 750
- Estimated value
- $0
- Report date
- 29 Jul 2026
- Price
- $35.59
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Medical Officer
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 13,500
- Estimated value
- Report date
- 18 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jonathan Rubin in SUPERNUS PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.